US Stock MarketDetailed Quotes

SHPH Shuttle Pharmaceuticals

Watchlist
  • 0.406
  • -0.014-3.33%
Close Mar 28 16:00 ET
  • 0.423
  • +0.017+4.16%
Post 19:45 ET
6.82MMarket Cap-922P/E (TTM)

About Shuttle Pharmaceuticals Company

Shuttle Pharmaceuticals Holdings, Inc. is a clinical stage pharmaceutical company, which engages in the development of novel therapies for cancer. It also offers cancer treatments with surgery, radiation therapy, chemotherapy, and immunotherapy. The company was founded by Anatoly Dritschilo, Mira Jung, and Milton Brown on December 18, 2012 and is headquartered in Gaithersburg, MD.

Company Profile

SymbolSHPH
Company NameShuttle Pharmaceuticals
Listing Date08/31/2022
Issue Price8.12
Founded2012
CEODr. Anatoly Dritschilo, M.D.
MarketNASDAQ
Employees8
Securities TypeOrdinary Shares
Fiscal Year Ends12-31
Address401 Professional Drive,Suite 260
CityGaithersburg
ProvinceMaryland
CountryUnited States of America
Zip Code20879
Phone1-240-403-4212

Company Executives

  • Name
  • Position
  • Salary
  • Dr. Anatoly Dritschilo, M.D.
  • Chairman of the Board and Chief Executive Officer
  • 263.09K
  • Michael P. Vander Hoek
  • Chief Financial Officer, Vice President, Operations and Regulatory and Principal Accounting Officer
  • 125.48K
  • Peter Dritschilo
  • President and Chief Operating Officer
  • 172.62K
  • Dr. Mira Jung, M.A.,PhD
  • Chief Scientific Officer, Biology
  • --
  • Dr. Tyvin A. Rich, M.D.
  • Chief Clinical Officer
  • 94.07K
  • Dr. Milton Brown, M.D.,PhD
  • Director
  • --
  • Joshua Schafer
  • Independent Director
  • --
  • Steven Richards, C.P.A.
  • Independent Director
  • --
  • Dr. Christoopher H. Senanayake, PhD
  • Independent Director
  • --
  • Dr. Bette Jacobs, PhD
  • Independent Director
  • --

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg